Victory Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,148
| Closed | -$125K | – | 2551 |
|
|
2025
Q1 | $125K | Buy |
10,148
+119
| +1% | +$1.46K | ﹤0.01% | 2284 |
|
|
2024
Q4 | $133K | Sell |
10,029
-56
| -0.6% | -$740 | ﹤0.01% | 2302 |
|
|
2024
Q3 | $194K | Sell |
10,085
-255
| -2% | -$4.91K | ﹤0.01% | 2232 |
|
|
2024
Q2 | $212K | Sell |
10,340
-265
| -2% | -$5.44K | ﹤0.01% | 2188 |
|
|
2024
Q1 | $252K | Buy |
+10,605
| New | +$252K | ﹤0.01% | 2159 |
|
|
2023
Q2 | – | Sell |
-16,033
| Closed | -$339K | – | 2594 |
|
|
2023
Q1 | $339K | Sell |
16,033
-5,871
| -27% | -$124K | ﹤0.01% | 2114 |
|
|
2022
Q4 | $557K | Sell |
21,904
-6,160
| -22% | -$157K | ﹤0.01% | 1976 |
|
|
2022
Q3 | $675K | Buy |
28,064
+6,656
| +31% | +$160K | ﹤0.01% | 1912 |
|
|
2022
Q2 | $412K | Buy |
21,408
+1,582
| +8% | +$30.4K | ﹤0.01% | 2136 |
|
|
2022
Q1 | $332K | Buy |
+19,826
| New | +$332K | ﹤0.01% | 2262 |
|
|
2020
Q2 | – | Sell |
-8,572
| Closed | -$94K | – | 3185 |
|
|
2020
Q1 | $94K | Buy |
+8,572
| New | +$94K | ﹤0.01% | 2553 |
|
|
2019
Q4 | – | Sell |
-4,440
| Closed | -$33K | – | 3195 |
|
|
2019
Q3 | $33K | Buy |
+4,440
| New | +$33K | ﹤0.01% | 2867 |
|